Kaya et al identified risk factors for contrast-induced nephropathy (CIN) in patients undergoing percutaneous coronary interventions (PCI). These can help to identify a patient who may benefit from more aggressive management. The authors are from Ordu University and Erzurum Education and Research Hospital in Turkey.